MXPA03007655A - Dosificacion metronomica de taxanos. - Google Patents

Dosificacion metronomica de taxanos.

Info

Publication number
MXPA03007655A
MXPA03007655A MXPA03007655A MXPA03007655A MXPA03007655A MX PA03007655 A MXPA03007655 A MX PA03007655A MX PA03007655 A MXPA03007655 A MX PA03007655A MX PA03007655 A MXPA03007655 A MX PA03007655A MX PA03007655 A MXPA03007655 A MX PA03007655A
Authority
MX
Mexico
Prior art keywords
taxanes
metronomic dosing
metronomic
dosing
Prior art date
Application number
MXPA03007655A
Other languages
English (en)
Inventor
Pamela A Trail
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MXPA03007655A publication Critical patent/MXPA03007655A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Carpets (AREA)
  • Epoxy Compounds (AREA)
MXPA03007655A 2001-02-28 2002-02-26 Dosificacion metronomica de taxanos. MXPA03007655A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28
PCT/US2002/005971 WO2002067928A2 (en) 2001-02-28 2002-02-26 Metronomic dosing of taxanes for inhibiting tumor growth

Publications (1)

Publication Number Publication Date
MXPA03007655A true MXPA03007655A (es) 2003-12-04

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007655A MXPA03007655A (es) 2001-02-28 2002-02-26 Dosificacion metronomica de taxanos.

Country Status (31)

Country Link
EP (1) EP1372636B1 (es)
JP (1) JP2004538253A (es)
KR (1) KR20030086276A (es)
CN (1) CN1533273A (es)
AR (1) AR033609A1 (es)
AT (1) ATE331511T1 (es)
BG (1) BG108167A (es)
BR (1) BR0207519A (es)
CA (1) CA2439299A1 (es)
CY (1) CY1105468T1 (es)
CZ (1) CZ20032232A3 (es)
DE (2) DE02723255T1 (es)
DK (1) DK1372636T3 (es)
EE (1) EE200300413A (es)
ES (1) ES2211374T3 (es)
HR (1) HRP20030775A2 (es)
HU (1) HUP0402115A2 (es)
IL (1) IL157356A0 (es)
IS (1) IS6924A (es)
MX (1) MXPA03007655A (es)
NO (1) NO20033809L (es)
PE (1) PE20020955A1 (es)
PL (1) PL373376A1 (es)
PT (1) PT1372636E (es)
RU (1) RU2003129233A (es)
SK (1) SK10332003A3 (es)
TR (1) TR200400375T3 (es)
UY (1) UY27185A1 (es)
WO (1) WO2002067928A2 (es)
YU (1) YU66603A (es)
ZA (1) ZA200306450B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US20080063699A1 (en) * 2003-10-15 2008-03-13 Michael Teifel Method of Administering Cationic Liposomes Comprising an Active Drug
US9233094B2 (en) 2005-05-04 2016-01-12 Medigene Ag Method of administering a cationic liposomal preparation
CA2646156C (en) 2006-03-22 2016-05-24 Medigene Ag Treatment of triple receptor negative breast cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1550231A (zh) * 1997-05-27 2004-12-01 �Ϳˡ�ŵ��ҩ�����޹�˾ 给予病人口服紫杉烷类药物的方法和组合物
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
HRP20030775A2 (en) 2005-02-28
WO2002067928A2 (en) 2002-09-06
HUP0402115A2 (hu) 2005-02-28
CY1105468T1 (el) 2010-04-28
KR20030086276A (ko) 2003-11-07
SK10332003A3 (sk) 2005-03-04
EP1372636A2 (en) 2004-01-02
BR0207519A (pt) 2005-03-08
YU66603A (sh) 2006-08-17
DE60212813D1 (de) 2006-08-10
PE20020955A1 (es) 2002-10-30
NO20033809D0 (no) 2003-08-27
AR033609A1 (es) 2003-12-26
DK1372636T3 (da) 2006-11-06
DE60212813T2 (de) 2007-01-18
ES2211374T1 (es) 2004-07-16
EP1372636B1 (en) 2006-06-28
JP2004538253A (ja) 2004-12-24
IL157356A0 (en) 2004-02-19
ZA200306450B (en) 2004-11-19
CN1533273A (zh) 2004-09-29
WO2002067928A3 (en) 2003-10-09
UY27185A1 (es) 2002-09-30
DE02723255T1 (de) 2004-07-15
RU2003129233A (ru) 2005-02-10
ATE331511T1 (de) 2006-07-15
NO20033809L (no) 2003-10-23
TR200400375T3 (tr) 2004-04-21
EE200300413A (et) 2003-12-15
ES2211374T3 (es) 2007-03-01
CA2439299A1 (en) 2002-09-06
PT1372636E (pt) 2006-09-29
IS6924A (is) 2003-08-22
CZ20032232A3 (en) 2004-06-16
PL373376A1 (en) 2005-08-22
BG108167A (en) 2004-09-30

Similar Documents

Publication Publication Date Title
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
MXPA03007834A (es) Uso de agonistas inversos de gabaa, en combinacion con agonistas parciales del receptor de nicotina, estrogenos, moduladores selectivos de estrogenos o vitamina e, para el tratamiento de transtornos cognitivos.
IL152129A0 (en) Flowmeter
EG23387A (en) Spirocyclic 3-phenyl-3-substituted 4-ketolactams and-lactones.
MXPA03008527A (es) Nueva tecnica de medicion.
DE50214751D1 (de) Dosiervorrichtung
DK1429628T3 (da) Baseholdig mikronæringsstofblanding
EP1363390A4 (en) OSCILLATOR
ZA200306450B (en) Metronomic dosing of taxanes.
DE60223671D1 (de) Dosierpumpe
DE50213685D1 (de) Dosiervorrichtung
GB0105323D0 (en) Multi zone clock
GB2388047B (en) Game
HK1050120A1 (en) Watchband.
AU147596S (en) Clock
TW475441U (en) Oscillator
GB0130856D0 (en) Game
CA93976S (en) Clock
CA92236S (en) Clock
CA93268S (en) Clock
CA93345S (en) Clock
CA92631S (en) Stopwatch
CA92740S (en) Stopwatch
CA92739S (en) Stopwatch
CA92744S (en) Stopwatch